[Federal Register Volume 87, Number 93 (Friday, May 13, 2022)]
[Notices]
[Pages 29316-29318]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-10380]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-22-22FI; Docket No. CDC-2022-0064]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), as part of 
its continuing effort to reduce public burden and maximize the utility 
of government information, invites the general public and other federal 
agencies the opportunity to comment on a proposed information 
collection, as required by the Paperwork Reduction Act of 1995. This 
notice invites comment on a proposed information collection project 
titled National HIV Behavioral Surveillance: Brief HIV Bio-behavioral 
Assessment (NHBS-BHBA). CDC is requesting approval to collect data on 
behaviors related to HIV infection and prevention among priority 
populations at high risk for HIV using mixed methods in selected 
geographic

[[Page 29317]]

areas across two funded states in the United States.

DATES: CDC must receive written comments on or before July 12, 2022.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0064, by either of the following methods:
     Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to www.regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (www.regulations.gov) or by U.S. mail to the address listed 
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:

    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden 
of the proposed collection of information, including the validity of 
the methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information 
to be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., 
permitting electronic submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    National HIV Behavioral Surveillance: Brief HIV Bio-behavioral 
Assessment (NHBS-BHBA)--New--National Center for HIV, Viral Hepatitis, 
STD, and TB Prevention (NCHHSTP), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The purpose of this data collection is to monitor behaviors of 
populations at high risk for Human Immunodeficiency Virus (HIV) 
infection using mixed-methods in selected geographic areas in the 
United States which lack biobehavioral data related to HIV transmission 
and prevention.
    Preventing HIV, especially among populations at high risk, is an 
effective strategy for reducing individual, local, and national 
healthcare costs. The utility of this information is to provide CDC and 
health department staff with data for evaluating progress towards state 
public health goals, such as reducing new HIV infections, increasing 
the use of condoms, and focusing on populations at high risk by 
describing and monitoring the HIV risk behaviors, HIV seroprevalence 
and incidence, and HIV prevention experiences of persons at highest 
risk for HIV infection. Data will be systematically collected using 
mixed methods of quantitative and qualitative interviews. Brief 
screening interviews will be used to determine eligibility for 
participation in the quantitative and qualitative interviews.
    Project teams will conduct brief standardized quantitative 
interviews and anonymous HIV blood-based rapid testing and supplemental 
testing to those who participate in quantitative data collection to 
assess HIV seroprevalence. The data from the quantitative interviews 
will provide estimates of: (1) Behavior related to the risk of HIV and 
other sexually transmitted diseases, (2) prior testing for HIV, and (3) 
use of HIV prevention services. HIV screening results will be made 
available to participants, and those with preliminary positive test 
results will be linked to HIV care. Qualitative data collection 
includes key informant interviews with community members and 
professionals familiar with the population and focus groups to 
interpret standardized quantitative findings and inform grantee-
developed recommendations for state/local public health partners. The 
data from qualitative interviews will be used to interpret standardized 
quantitative findings and inform recipient-developed recommendations 
for state and local public health authorities. No other federal agency 
collects this type of information in the populations at high risk in 
these selected geographic areas using mixed methods of quantitative and 
qualitative interviews.
    CDC estimates that during quantitative interviewing, 1338 
individuals will complete the quantitative base eligibility screener, 
1204 will complete the quantitative population eligibility screener, 
and 338 will be either not interested or ineligible, yielding a total 
of 1,000 eligible respondents over a 12-month period. Because HIV 
testing is a clinical procedure, it is not included in the burden 
estimates. For qualitative data collection, approximately 96 
individuals will complete the eligibility screener, 16 of the 
respondents will be either not interested in completing a qualitative 
interview, or will be ineligible, yielding a total of 80 eligible 
respondents over a 12-month period.
    CDC requests OMB approval for an estimated 497 annual burden hours. 
Participation of respondents is voluntary, and there are no costs to 
respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Persons Screened..............  Quantitative               1,338               1            1/60              23
                                 Base
                                 Eligibility
                                 Screener.
Persons Screened..............  Quantitative               1,204               1            5/60             101
                                 Population
                                 Eligibility
                                 Screener.
Eligible Participants.........  Quantitative               1,000               1           10/60             167
                                 Core Survey.

[[Page 29318]]

 
Eligible Participants.........  Quantitative               1,000               1            5/60              84
                                 Population-
                                 specific
                                 Questions.
Persons Screened..............  Qualitative                   96               1            1/60               2
                                 Eligibility
                                 Screener.
Eligible Participant..........  Qualitative                   80               1           90/60             120
                                 Interviews.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             497
----------------------------------------------------------------------------------------------------------------


Jeffery M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-10380 Filed 5-12-22; 8:45 am]
BILLING CODE 4163-18-P